Pediatric Oncall
facebook
twitter
youtube
instagram
rss
Home
Videos

Dr. Ira Shah: Tuberculosis Treatment Guidelines 2016
 
fb
twitter
print
https://i.ytimg.com/vi/kZoDQS8xqMM/mqdefault.jpg 02/26/2016 11:34:58 Dr. Ira Shah talks about tuberculosis treatment guidelines-practical diagnostic dilemmas in clinical practice are routinely faced as worsening of TB or paradoxical reaction.
The paradoxical phenomenon of the appearance of tuberculomas while on successful antituberculous therapy is supposed to be due to an immunological reaction. Difficult to distinguish between drug resistance and paradoxical reaction. Responds to the same ATT and may require steroids. Restarted on steroids and second-line ATT was continued. After 11 months, weight is increasing with normal milestones and on regular follow up. As physicians, our first goal should be DO NO HARM….. A close analysis may help to prevent overtreatment and under-treatment.
-~-~~-~~~-~~-~-
For more info visit our WEBSITE Pediatric Oncall: https://www.pediatriconcall.com/
SUBSCRIBE to Pediatric Oncall for more such videos: https://www.youtube.com/pediatriconcall
FOLLOW us on social media pages for updates and regular case discussions:
Facebook: www.facebook.com/PediatricOncall/
Instagram: https://www.instagram.com/pediatriconcall
Twitter: https://twitter.com/pediatriconcall
-~-~~-~~~-~~-~-
Also, check out Dr Ira Shah: Diagnosis of TB-When to Treat and Not to Treat
https://youtu.be/1n6ZT9KQvvA

Dr. Ira Shah: Tuberculosis Treatment Guidelines 2016

Description
Dr. Ira Shah talks about tuberculosis treatment guidelines-practical diagnostic dilemmas in clinical practice are routinely faced as worsening of TB or paradoxical reaction.
The paradoxical phenomenon of the appearance of tuberculomas while on successful antituberculous therapy is supposed to be due to an immunological reaction. Difficult to distinguish between drug resistance and paradoxical reaction. Responds to the same ATT and may require steroids. Restarted on steroids and second-line ATT was continued. After 11 months, weight is increasing with normal milestones and on regular follow up. As physicians, our first goal should be DO NO HARM….. A close analysis may help to prevent overtreatment and under-treatment.
-~-~~-~~~-~~-~-
For more info visit our WEBSITE Pediatric Oncall: https://www.pediatriconcall.com/
SUBSCRIBE to Pediatric Oncall for more such videos: https://www.youtube.com/pediatriconcall
FOLLOW us on social media pages for updates and regular case discussions:
Facebook: www.facebook.com/PediatricOncall/
Instagram: https://www.instagram.com/pediatriconcall
Twitter: https://twitter.com/pediatriconcall
-~-~~-~~~-~~-~-
Also, check out Dr Ira Shah: Diagnosis of TB-When to Treat and Not to Treat
https://youtu.be/1n6ZT9KQvvA
More videos
ask a doctor
Ask a Doctor
Book Store
Dengue, Malaria, Leptospirosis & Typhoid Dengue, Malaria, Leptospirosis & Typhoid
Order Now
Join Us
facebook
twitter
youtube
instagram
rss
Pediatric Oncall
Pediatric Oncall
Medical Calculators
Medical Calculators
Drug Center
Drug Center
Pediatric Oncall Journal
Pediatric Oncall Journal
Parenting
Parenting
Vaccine Reminder
Vaccine Reminder

Home

 About Us
Link To Us
Terms & Conditions
Privacy Policy

 
Online Ordering Policy
Sitemap
Feedback

Partner Sites

HIV in Childern
Vaccine Reminder
Pediatric Oncall Journal
Infection In Children

New Arrival

Infection In Children

Other Pediatric Oncall Books
View More Books
DMCA
COPYSCAPE
Copyright © 2001 - 2024 Pediatric Oncall All Rights Reserved. All trademarks used are the properties of their respective owners.
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0